Meeting
2022 ASCO Genitourinary Cancers Symposium
Bladder volume variation in hypofractionated prostate radiotherapy.
Authors
Ronan Joyce
St Luke's Radiation Oncology Network, Dublin, Ireland
Ronan Joyce , Jake Murphy , Eoin O'Neill , Ciara A. Lyons
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Quality of Care/Quality Improvement and Real-World Evidence
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 234)
DOI
10.1200/JCO.2022.40.6_suppl.234
Abstract #
234
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Out-of-pocket cost modeling of adjuvant radiation therapy duration in standard-of-care treatment of glioblastoma across Medicaid and Medicare plans.
First Author: Victoria Wu
Poster
2023 ASCO Breakthrough
Dosimetric feasibility of dose-painting radiotherapy for targeting hypoxia in prostate cancer on a novel ring gantry radiotherapy system.
First Author: Karine Feghali
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Hypofractionated radiotherapy to the pancreas: U.K. experience.
First Author: Suliana Teoh
Poster
2018 ASCO Annual Meeting
RM-1929 photo-immunotherapy in patients with recurrent head and neck cancer: Results of a multicenter phase 2a open-label clinical trial.
First Author: Ann M. Gillenwater